'On par with the biggest breakthroughs in medicine': Spokane doctor discovers new kidney disease treatment. An 11000-person study will start in 2024 - The Spokesman Review

4 months ago 66

'On par with the biggest breakthroughs in medicine': Spokane doctor discovers new kidney disease treatment. An 11000-person study will start in 2024 The Spokesman Review
Significant benefit seen in Phase III trial of experimental drug for kidney disease Medical Xpress
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial The Lancet
Kidney Disease Drug Candidate Shows Broad Inhibition of Damaging Hormone Inside Precision Medicine
New Aldosterone Synthase Inhibitor BI 690517 Shows Promise in Reducing Albuminuria HealthDay

Read Entire Article